SarcoMed USA
PrivateMomentum
Top 50%
of companies Caplight tracks
Company Overview
SarcoMed USA operates in Healthcare & Life Sciences and is based in Houston, Texas. It was founded in 2017.
SarcoMed USA is a biotechnology company focused on the development of novel inhaled therapies for pulmonary sarcoidosis and other respiratory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SarcoMed USA Comparables
Compare SarcoMed USA with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Xentria, Inc. | 78% | |
| aTyr Pharma | 76% | |
| MSICS Pharma | 74% |
For institutional investors. Book with your work email.
SarcoMed USA Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 53% MoM, reaching 1.2K.
For institutional investors. Book with your work email.
SarcoMed USA Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about SarcoMed USA's valuation, stock price, and market status.
Is SarcoMed USA a public or private company?
SarcoMed USA is a private company.
What is the current stock price of SarcoMed USA?
SarcoMed USA is a private company, so its shares have no public market price. Caplight tracks SarcoMed USA's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is SarcoMed USA worth (valuation)?
Valuation information for SarcoMed USA is not publicly available.
Can I buy SarcoMed USA stock?
SarcoMed USA shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was SarcoMed USA's last funding round?
Funding round information for SarcoMed USA is not publicly available.
Who are the main investors in SarcoMed USA?
Investor information for SarcoMed USA is not publicly disclosed.
Will SarcoMed USA IPO soon?
No public IPO plans have been announced for SarcoMed USA.
How can I track SarcoMed USA secondary market activity?
Caplight tracks bids, offers, and trades in SarcoMed USA's shares on secondary markets.